BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prichard R, Ménez C, Lespine A. Moxidectin and the avermectins: Consanguinity but not identity. Int J Parasitol Drugs Drug Resist 2012;2:134-53. [PMID: 24533275 DOI: 10.1016/j.ijpddr.2012.04.001] [Cited by in Crossref: 159] [Cited by in F6Publishing: 148] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Hürlimann E, Hofmann D, Keiser J. Ivermectin and moxidectin against soil-transmitted helminth infections. Trends Parasitol 2023;39:272-84. [PMID: 36804383 DOI: 10.1016/j.pt.2023.01.009] [Reference Citation Analysis]
2 Takano K, de Hayr L, Carver S, Harvey RJ, Mounsey KE. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife. Int J Parasitol Drugs Drug Resist 2023;21:97-113. [PMID: 36906936 DOI: 10.1016/j.ijpddr.2023.02.004] [Reference Citation Analysis]
3 Pfarr KM, Krome AK, Al-Obaidi I, Batchelor H, Vaillant M, Hoerauf A, Opoku NO, Kuesel AC. The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration. Parasit Vectors 2023;16:82. [PMID: 36859332 DOI: 10.1186/s13071-022-05581-4] [Reference Citation Analysis]
4 Rowland Yeo K, Wesche D. PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile. CPT Pharmacometrics Syst Pharmacol 2023. [PMID: 36840414 DOI: 10.1002/psp4.12950] [Reference Citation Analysis]
5 Taghinezhad-s S, Mohseni AH, Jiang W, Casolaro V, Bermúdez-humarán LG, Mcallister F, Lv Z, Li D. Host-microbe interactions mediate doramectin-promoted metabolic reprogramming of CD8+T-cells and amplify antitumor immunity.. [DOI: 10.1101/2023.01.29.525543] [Reference Citation Analysis]
6 Mitchell E, Tielemans E, Mccall JW, Baker C, Martin E, Frost J, Yoon S, Fankhauser B. Efficacy for the prevention of heartworm disease in dogs of an oral combination of moxidectin, afoxolaner, and pyrantel pamoate. Research in Veterinary Science 2022. [DOI: 10.1016/j.rvsc.2022.11.012] [Reference Citation Analysis]
7 Geary TG, Long A, Tritten L. Current Antifilarial Drugs – Mechanisms of Action. Human and Animal Filariases 2022. [DOI: 10.1002/9783527823413.ch10] [Reference Citation Analysis]
8 Hawryluk* NA. The Antifilarial Drug Pipeline. Human and Animal Filariases 2022. [DOI: 10.1002/9783527823413.ch18] [Reference Citation Analysis]
9 Ketzis J, Epe C. Antifilarial Chemotherapy: Current Options in Veterinary Medicine. Human and Animal Filariases 2022. [DOI: 10.1002/9783527823413.ch8] [Reference Citation Analysis]
10 Ibrahim KA, Eleyan M, Khwanes SA, Mohamed RA, Ayesh BM. Alpha-mangostin attenuates the apoptotic pathway of abamectin in the fetal rats' brain by targeting pro-oxidant stimulus, catecholaminergic neurotransmitters, and transcriptional regulation of reelin and nestin. Drug Chem Toxicol 2022;45:2496-508. [PMID: 34338122 DOI: 10.1080/01480545.2021.1960856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Radwan M, El-sharkawy MA, Negm MA, Mohammadein A, Malki J, Al-thomali AW, Mohamed A, Yassir S, Bashar MA. Dual effect of dietary seaweed of extract nanoparticles (GNS) with bionanocomposite cellulose acetate membranes (CA/bio-AgNps) on growth performance and health status of the Nile tilapia (Oreochromis niloticus): Specification on feed utilization, immune system, and antiparasitic action. Front Mar Sci 2022;9. [DOI: 10.3389/fmars.2022.1008397] [Reference Citation Analysis]
12 Buonfrate D, Rodari P, Barda B, Page W, Einsiedel L, Watts M. Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment. Expert Opin Pharmacother 2022. [PMID: 35983698 DOI: 10.1080/14656566.2022.2114829] [Reference Citation Analysis]
13 Jakobs N, Yilmaz E, Krücken J. Transgenic Expression of Haemonchus contortus Cytochrome P450 Hco-cyp-13A11 Decreases Susceptibility to Particular but Not All Macrocyclic Lactones in the Model Organism Caenorhabditis elegans. IJMS 2022;23:9155. [DOI: 10.3390/ijms23169155] [Reference Citation Analysis]
14 Gupta S, Vohra S, Sethi K, Gupta S, Bera BC, Kumar S, Kumar R. In vitro anti-trypanosomal effect of ivermectin on Trypanosoma evansi by targeting multiple metabolic pathways. Trop Anim Health Prod 2022;54. [DOI: 10.1007/s11250-022-03228-1] [Reference Citation Analysis]
15 Pastore VAA, Santos FA, Lana MAG, Silva GR, Figueiredo TC, Assis DCS, Cançado SV. Development and Validation of a Multiresidue Method for the Determination of Macrocyclic Lactones, Monensin, and Fipronil in Bovine Liver by UHPLC-MS/MS Using a QuEChERS Extraction. Food Anal Methods. [DOI: 10.1007/s12161-022-02354-8] [Reference Citation Analysis]
16 Bains J, Carver S, Hua S. Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery. Front Vet Sci 2022;9:944578. [DOI: 10.3389/fvets.2022.944578] [Reference Citation Analysis]
17 DeMel D, Gleeson M, Schachterle K, Thomer A. Successful treatment of ivermectin overdose in a bearded dragon (Pogona vitticeps) using gastric lavage and intravenous lipid emulsion. J Vet Emerg Crit Care (San Antonio) 2022. [PMID: 35708909 DOI: 10.1111/vec.13218] [Reference Citation Analysis]
18 Voigt K, Geiger M, Jäger MC, Knubben-schweizer G, Strube C, Zablotski Y. Effectiveness of Anthelmintic Treatments in Small Ruminants in Germany. Animals 2022;12:1501. [DOI: 10.3390/ani12121501] [Reference Citation Analysis]
19 Akgöl J, Köroğlu A. UYUZ HASTALIĞI (SKABİYES), TEDAVİSİ VE UYUZ HASTALIĞI TEDAVİSİNDE KULLANILAN BİTKİLER. Ankara Universitesi Eczacilik Fakultesi Dergisi 2022. [DOI: 10.33483/jfpau.1085681] [Reference Citation Analysis]
20 Ferreira LC, Lima EF, Silva ALP, Oliveira CSM, Silva Filho GM, Sousa LC, Klafke GM, Feitosa TF, Vilela VLR. Cross-resistance between macrocyclic lactones in populations of Rhipicephalus microplus in Brazil's semiarid region. Exp Appl Acarol 2022;87:109-17. [PMID: 35817880 DOI: 10.1007/s10493-022-00730-x] [Reference Citation Analysis]
21 Bakajika D, Kanza EM, Opoku NO, Howard HM, Mambandu GL, Nyathirombo A, Nigo MM, Kennedy KK, Masembe SL, Mumbere M, Kataliko K, Bolay KM, Attah SK, Olipoh G, Asare S, Vaillant M, Halleux CM, Kuesel AC. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection. PLoS Negl Trop Dis 2022;16:e0010079. [DOI: 10.1371/journal.pntd.0010079] [Reference Citation Analysis]
22 Borges DGL, Conde MH, Cunha CCT, De Freitas MG, Moro E, De Almeida Borges F. Moxidectin: A Viable Alternative for the Control of Ivermectin-Resistant Gastrointestinal Nematodes in Beef Cattle. Acta Veterinaria 2022;72:16-29. [DOI: 10.2478/acve-2022-0002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Savadelis MD, McTier TL, Kryda K, Maeder SJ, Woods DJ. Moxidectin: heartworm disease prevention in dogs in the face of emerging macrocyclic lactone resistance. Parasit Vectors 2022;15:82. [PMID: 35277180 DOI: 10.1186/s13071-021-05104-7] [Reference Citation Analysis]
24 Salman M, Abbas RZ, Mehmood K, Hussain R, Shah S, Faheem M, Zaheer T, Abbas A, Morales B, Aneva I, Martínez JL. Assessment of Avermectins-Induced Toxicity in Animals. Pharmaceuticals 2022;15:332. [DOI: 10.3390/ph15030332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Bakajika D, Kanza EM, Opoku NO, Howard HM, Mambandu GL, Nyathirombo A, Nigo MM, Kennedy KK, Masembe SL, Mumbere M, Kataliko K, Bolay KM, Attah SK, Olipoh G, Asare S, Vaillant M, Halleux CM, Kuesel AC. Effect of a single dose of 8 mg moxidectin or 150 µg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.. [DOI: 10.1101/2022.02.22.22271335] [Reference Citation Analysis]
26 Mounsey K, Harvey RJ, Wilkinson V, Takano K, Old J, Stannard H, Wicker L, Phalen D, Carver S. Drug dose and animal welfare: important considerations in the treatment of wildlife. Parasitol Res 2022. [PMID: 35147771 DOI: 10.1007/s00436-022-07460-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ouattara M, Uj-p N'guessan D, Coulibaly S. Pharmacotherapy of gastrointestinal strongylosis of small ruminants: An update. IJPCA 2022;8:159-166. [DOI: 10.18231/j.ijpca.2021.031] [Reference Citation Analysis]
28 Chable-bessia C, Boullé C, Neyret A, Swain J, Hénaut M, Merida P, Gros N, Makinson A, Lyonnais S, Chesnais C, Muriaux D. Low Selectivity Indices of Ivermectin and Macrocyclic Lactones on SARS-CoV-2 Replication In Vitro. COVID 2022;2:60-75. [DOI: 10.3390/covid2010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Dutra FVA, Teixeira LS, Pires BC, Florez DHÂ, Teixeira RA, Borges KB. Development and validation of analytical methods by HPLC for quality control of avermectins and milbemycins in bulk samples. Braz J Pharm Sci 2022;58:e19587. [DOI: 10.1590/s2175-97902022e19587] [Reference Citation Analysis]
30 Mackenzie SL, Hall G, Schaerf TM, Andrew NR. Impacts of macrocyclic lactones on larval survival, growth and development of three dung beetle species (Coleoptera: Scarabaeidae). Austral Entomology. [DOI: 10.1111/aen.12580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chable-bessia C, Boullé C, Neyret A, Swain J, Hénaut M, Merida P, Gros N, Makinson A, Lyonnais S, Chesnais CB, Muriaux D. Low selectivity index of ivermectin and macrocyclic lactones on SARS-CoV2 replication in vitro argues against their therapeutic use for COVID-19.. [DOI: 10.1101/2021.11.01.466865] [Reference Citation Analysis]
32 Prichard RK. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease. Int J Parasitol 2021;51:1121-32. [PMID: 34717929 DOI: 10.1016/j.ijpara.2021.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Stavrakaki M, Ilias A, Ioannidis P, Vontas J, Roditakis E. Investigating mechanisms associated with emamectin benzoate resistance in the tomato borer Tuta absoluta. J Pest Sci. [DOI: 10.1007/s10340-021-01448-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Borges DGL, de Almeida Borges F, Vieira MC, Pupin RC, de Araújo MA, de Castro Guizelini C, de Lemos RAA. Poisoning of calves reared with cows treated with abamectin. Toxicon 2021;203:115-6. [PMID: 34662630 DOI: 10.1016/j.toxicon.2021.10.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Ngwewondo A, Scandale I, Specht S. Onchocerciasis drug development: from preclinical models to humans. Parasitol Res 2021;120:3939-64. [PMID: 34642800 DOI: 10.1007/s00436-021-07307-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
36 Dinesh Kumar N, Ter Ellen BM, Bouma EM, Troost B, van de Pol DPI, van der Ende-Metselaar HH, van Gosliga D, Apperloo L, Carpaij OA, van den Berge M, Nawijn MC, Stienstra Y, Rodenhuis-Zybert IA, Smit JM. MOXIDECTIN AND IVERMECTIN INHIBIT SARS-COV-2 REPLICATION IN VERO E6 CELLS BUT NOT IN HUMAN PRIMARY AIRWAY EPITHELIUM CELLS. Antimicrob Agents Chemother 2021;:AAC0154321. [PMID: 34633839 DOI: 10.1128/AAC.01543-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
37 Jimenez Castro PD, Venkatesan A, Redman E, Chen R, Malatesta A, Huff H, Zuluaga Salazar DA, Avramenko R, Gilleard JS, Kaplan RM. Multiple drug resistance in hookworms infecting greyhound dogs in the USA. Int J Parasitol Drugs Drug Resist 2021;17:107-17. [PMID: 34492564 DOI: 10.1016/j.ijpddr.2021.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Grell T, Barbero M, Pattarino F, Giovenzana GB, Colombo V. Solvatomorphism of Moxidectin. Molecules 2021;26:4869. [PMID: 34443452 DOI: 10.3390/molecules26164869] [Reference Citation Analysis]
39 Jacobson LS, DiGangi BA. An Accessible Alternative to Melarsomine: "Moxi-Doxy" for Treatment of Adult Heartworm Infection in Dogs. Front Vet Sci 2021;8:702018. [PMID: 34386540 DOI: 10.3389/fvets.2021.702018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mayinda GD, Serreau D, Gesbert A, Reigner F, Sutra JF, Lespine A, Sallé G. Ivermectin treatment in lactating mares results in suboptimal ivermectin exposure in their suckling foals. Vet Parasitol 2021;296:109511. [PMID: 34237517 DOI: 10.1016/j.vetpar.2021.109511] [Reference Citation Analysis]
41 Heinrich AP, Zöltzer T, Böhm L, Wohde M, Jaddoudi S, El Maataoui Y, Dahchour A, Düring RA. Sorption of selected antiparasitics in soils and sediments. Environ Sci Eur 2021;33:77. [PMID: 34249591 DOI: 10.1186/s12302-021-00513-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Tinkov OV, Grigorev VY, Grigoreva LD. QSAR analysis of the acute toxicity of avermectins towards Tetrahymena pyriformis. SAR QSAR Environ Res 2021;32:541-71. [PMID: 34157880 DOI: 10.1080/1062936X.2021.1932583] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Bousquet-Mélou A, Lespine A, Sutra JF, Bargues I, Toutain PL. A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients. Front Pharmacol 2021;12:666348. [PMID: 34093195 DOI: 10.3389/fphar.2021.666348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Kumar ND, ter Ellen BM, Bouma EM, Troost B, van de Pol DPI, van der Ende-metselaar HH, van Gosliga D, Apperloo L, Carpaij OA, van den Berge M, Nawijn MC, Stienstra Y, Rodenhuis-zybert IA, Smit JM. Moxidectin and ivermectin inhibit SARS-CoV-2 replication in Vero E6 cells but not in human primary airway epithelium cells.. [DOI: 10.1101/2021.05.17.444467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease - Overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist 2021;16:65-89. [PMID: 34030109 DOI: 10.1016/j.ijpddr.2021.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
46 Christensen SB. Natural Products That Changed Society. Biomedicines 2021;9:472. [PMID: 33925870 DOI: 10.3390/biomedicines9050472] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
47 Hassan SM, Ashour M, Soliman AAF, Hassanien HA, Alsanie WF, Gaber A, Elshobary ME. The Potential of a New Commercial Seaweed Extract in Stimulating Morpho-Agronomic and Bioactive Properties of Eruca vesicaria (L.) Cav. Sustainability 2021;13:4485. [DOI: 10.3390/su13084485] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
48 Muniz MS, Halbach K, Alves Araruna IC, Martins RX, Seiwert B, Lechtenfeld O, Reemtsma T, Farias D. Moxidectin toxicity to zebrafish embryos: Bioaccumulation and biomarker responses. Environ Pollut 2021;283:117096. [PMID: 33866217 DOI: 10.1016/j.envpol.2021.117096] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
49 Hassan SM, Ashour M, Sakai N, Zhang L, Hassanien HA, Gaber A, Ammar G. Impact of Seaweed Liquid Extract Biostimulant on Growth, Yield, and Chemical Composition of Cucumber (Cucumis sativus). Agriculture 2021;11:320. [DOI: 10.3390/agriculture11040320] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
50 Muñoz-Muñoz L, Shoen C, Sweet G, Vitoria A, Bull TJ, Cynamon M, Thompson CJ, Ramón-García S. Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. Antibiotics (Basel) 2021;10:381. [PMID: 33916775 DOI: 10.3390/antibiotics10040381] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Gerhard AP, Krücken J, Neveu C, Charvet CL, Harmache A, von Samson-Himmelstjerna G. Pharyngeal Pumping and Tissue-Specific Transgenic P-Glycoprotein Expression Influence Macrocyclic Lactone Susceptibility in Caenorhabditis elegans. Pharmaceuticals (Basel) 2021;14:153. [PMID: 33668460 DOI: 10.3390/ph14020153] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
52 Wu Y, Yang S, Zhang Z, Chen S. Improvement of Nemadectin Production by Overexpressing the Regulatory Gene nemR and Nemadectin Biosynthetic Gene Cluster in Streptomyces Cyaneogriseus. Pharmaceutical Fronts 2021;02:e151-9. [DOI: 10.1055/s-0040-1722746] [Reference Citation Analysis]
53 Hofmann D, Sayasone S, Keiser J. Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1166:122556. [PMID: 33535101 DOI: 10.1016/j.jchromb.2021.122556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
54 Couto LFM, Zapa DMB, Heller LM, Cavalcante ASA, Nicaretta JE, Cruvinel LB, Colli MHA, Ferreira LL, Alencar A, de Melo-Junior RD, Soares VE, Borges FA, Lopes WDZ. Gastrointestinal nematode control programs in yearling Nellore heifers: Analysis of fecal egg counts, weight gain and reproductive indices. Anim Reprod Sci 2021;226:106695. [PMID: 33485086 DOI: 10.1016/j.anireprosci.2021.106695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
55 Lynn RC, Duquette RA. Antiparasitic drugs. Georgis' Parasitology for Veterinarians 2021. [DOI: 10.1016/b978-0-323-54396-5.00015-5] [Reference Citation Analysis]
56 Xue W, Mermans C, Papapostolou KM, Lamprousi M, Christou IK, Inak E, Douris V, Vontas J, Dermauw W, Van Leeuwen T. Untangling a Gordian knot: the role of a GluCl3 I321T mutation in abamectin resistance in Tetranychus urticae. Pest Manag Sci 2021;77:1581-93. [PMID: 33283957 DOI: 10.1002/ps.6215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
57 Inam W, Walton S, Khan S, Mahmood W. Molecular drug targets for scabies: a medicinal chemistry perspective. Future Med Chem 2020;12:2225-38. [PMID: 33243012 DOI: 10.4155/fmc-2020-0182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Peterson EM, Green FB, Smith PN. Toxic responses of blue orchard mason bees (Osmia lignaria) following contact exposure to neonicotinoids, macrocyclic lactones, and pyrethroids. Ecotoxicol Environ Saf 2021;208:111681. [PMID: 33396013 DOI: 10.1016/j.ecoenv.2020.111681] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Korhonen PK, Gasser RB, Ma G, Wang T, Stroehlein AJ, Young ND, Ang CS, Fernando DD, Lu HC, Taylor S, Reynolds SL, Mofiz E, Najaraj SH, Gowda H, Madugundu A, Renuse S, Holt D, Pandey A, Papenfuss AT, Fischer K. High-quality nuclear genome for Sarcoptes scabiei-A critical resource for a neglected parasite. PLoS Negl Trop Dis 2020;14:e0008720. [PMID: 33001992 DOI: 10.1371/journal.pntd.0008720] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
60 Jacob J, Tan G, Lange I, Saeed H, Date A, Jarvi S. In vitro efficacy of anthelmintics on Angiostrongylus cantonensis L3 larvae. Parasitology 2021;148:240-50. [PMID: 32799943 DOI: 10.1017/S0031182020001146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
61 El-Saber Batiha G, Alqahtani A, Ilesanmi OB, Saati AA, El-Mleeh A, Hetta HF, Magdy Beshbishy A. Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects. Pharmaceuticals (Basel) 2020;13:E196. [PMID: 32824399 DOI: 10.3390/ph13080196] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
62 Kerr CL, Armstrong DR, Anderson AJ. Short communication: A practical farm-based trial to compare ewe nematode control strategies in peri-parturient ewes. PLoS One 2020;15:e0236143. [PMID: 32790679 DOI: 10.1371/journal.pone.0236143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Sharaf M, Antonios S, Mina S, Eliwa K, Rayia DA. The scabicide effect of moxidectin in vitro and in experimental animals: Parasitological, histopathological and immunological evaluation. Exp Parasitol 2020;217:107961. [PMID: 32777223 DOI: 10.1016/j.exppara.2020.107961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
64 Liu J, Liang H, Khilji S, Li H, Song D, Chen C, Wang X, Zhang Y, Zhao N, Li X, Gao A. Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway. J Cancer 2020;11:5802-11. [PMID: 32913473 DOI: 10.7150/jca.46697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Wang J, Ling Y, Zhou W, Li D, Deng Y, Yang X, Zhang F. Targeted analysis of six emerging derivatives or metabolites together with 25 common macrolides in milk using Quick, Easy, Cheap, Effective, Rugged and Safe extraction and ultra-performance liquid chromatography quadrupole/electrostaticfield orbitrap mass spectrometry. J Sep Sci 2020;43:3719-34. [PMID: 32725879 DOI: 10.1002/jssc.202000408] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Dusabimana A, Bhwana D, Raimon S, Mmbando BP, Hotterbeekx A, Tepage F, Mandro M, Siewe Fodjo JN, Abrams S, Colebunders R. Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study. Pathogens 2020;9:E617. [PMID: 32751060 DOI: 10.3390/pathogens9080617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
67 Milton P, Hamley JID, Walker M, Basáñez MG. Moxidectin: an oral treatment for human onchocerciasis. Expert Rev Anti Infect Ther 2020;18:1067-81. [PMID: 32715787 DOI: 10.1080/14787210.2020.1792772] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
68 Mezzatesta C, Abduli L, Guinot A, Eckert C, Schewe D, Zaliova M, Vinti L, Marovca B, Tsai YC, Jenni S, Aguade-Gorgorio J, von Stackelberg A, Schrappe M, Locatelli F, Stanulla M, Cario G, Bourquin JP, Bornhauser BC. Repurposing anthelmintic agents to eradicate resistant leukemia. Blood Cancer J 2020;10:72. [PMID: 32591499 DOI: 10.1038/s41408-020-0339-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
69 Reyes-Espinosa F, Nieto-Pescador MG, Bocanegra-García V, Lozano-Guzmán E, Rivera G. In Silico Analysis of FDA Drugs as P2X4 Modulators for the Treatment of Alcohol Use Disorder. Mol Inform 2020;39:e1900111. [PMID: 32511896 DOI: 10.1002/minf.201900111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Reyes-Guerrero DE, Cedillo-Borda M, Alonso-Morales RA, Alonso-Díaz MA, Olmedo-Juárez A, Mendoza-de-Gives P, López-Arellano ME. Comparative study of transcription profiles of the P-glycoprotein transporters of two Haemonchus contortus isolates: Susceptible and resistant to ivermectin. Mol Biochem Parasitol 2020;238:111281. [PMID: 32434064 DOI: 10.1016/j.molbiopara.2020.111281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
71 Avcı B, Filazi A. The effects of heat applications on macrocyclic lactone-structured antiparasitic drug residues in cows' milk. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2020;37:1145-55. [PMID: 32364005 DOI: 10.1080/19440049.2020.1753892] [Reference Citation Analysis]
72 Rodríguez‐vivas RI, Basto‐estrella GS, Reyes‐novelo E, Arceo‐moran AA, Arcila‐fuentes WR, Ojeda‐chi MM, Martínez‐m I. Evaluation of the attraction, lethal and sublethal effects of the faeces of ivermectin‐treated cattle on the dung beetle Digit onthophagus gazella (Coleoptera: Scarabaeidae). Austral Entomology 2020;59:368-374. [DOI: 10.1111/aen.12450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
73 Wang Z, Xue J, Sun H, Zhao M, Wang Y, Chu J, Zhuang Y. Evaluation of mixing effect and shear stress of different impeller combinations on nemadectin fermentation. Process Biochemistry 2020;92:120-129. [DOI: 10.1016/j.procbio.2020.02.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Flick AC, Leverett CA, Ding HX, Mcinturff E, Fink SJ, Helal CJ, Deforest JC, Morse PD, Mahapatra S, O’donnell CJ. Synthetic Approaches to New Drugs Approved during 2018. J Med Chem 2020;63:10652-704. [DOI: 10.1021/acs.jmedchem.0c00345] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
75 Xue W, Snoeck S, Njiru C, Inak E, Dermauw W, Van Leeuwen T. Geographical distribution and molecular insights into abamectin and milbemectin cross‐resistance in European field populations of Tetranychus urticae. Pest Manag Sci 2020;76:2569-81. [DOI: 10.1002/ps.5831] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
76 Jimenez Castro PD, Mansour A, Charles S, Hostetler J, Settje T, Kulke D, Kaplan RM. Efficacy evaluation of anthelmintic products against an infection with the canine hookworm (Ancylostoma caninum) isolate Worthy 4.1F3P in dogs. Int J Parasitol Drugs Drug Resist 2020;13:22-7. [PMID: 32403053 DOI: 10.1016/j.ijpddr.2020.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
77 Xu Y, Zhang S, Qiu Y, Yu Y, Zhang Y, Huang X. Pharmacokinetics of extended-release ivermectin microspheres after oral administration to healthy pigs. J Vet Pharmacol Ther 2020;43:485-90. [PMID: 32304335 DOI: 10.1111/jvp.12863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Hawryluk NA. Macrofilaricides: An Unmet Medical Need for Filarial Diseases. ACS Infect Dis 2020;6:662-71. [PMID: 32091199 DOI: 10.1021/acsinfecdis.9b00469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
79 Kotthoff L, O'Callaghan SL, Lisec J, Schwerdtle T, Koch M. Structural annotation of electro- and photochemically generated transformation products of moxidectin using high-resolution mass spectrometry. Anal Bioanal Chem 2020;412:3141-52. [PMID: 32172328 DOI: 10.1007/s00216-020-02572-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Jiao Y, Preston S, Hofmann A, Taki A, Baell J, Chang BCH, Jabbar A, Gasser RB. A perspective on the discovery of selected compounds with anthelmintic activity against the barber's pole worm-Where to from here? Adv Parasitol 2020;108:1-45. [PMID: 32291083 DOI: 10.1016/bs.apar.2019.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
81 Heuer L, Petry G, Pollmeier M, Schaper R, Deuster K, Schmidt H, Blazejak K, Strube C, Di Cesare A, Traversa D, Schnyder M, McKay-Demeler J, von Samson-Himmelstjerna G, Mangold-Gehring S, Böhm C. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis. Parasit Vectors 2020;13:65. [PMID: 32051008 DOI: 10.1186/s13071-020-3937-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
82 Bordes L, Dumont N, Lespine A, Souil E, Sutra JF, Prévot F, Grisez C, Romanos L, Dailledouze A, Jacquiet P. First report of multiple resistance to eprinomectin and benzimidazole in Haemonchus contortus on a dairy goat farm in France. Parasitol Int 2020;76:102063. [PMID: 31978599 DOI: 10.1016/j.parint.2020.102063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
83 Bhardwaj K, Abraham J, Kaur S. Natural Product as Avermectins and Milbemycins for Agriculture Perspectives. Natural Bioactive Products in Sustainable Agriculture 2020. [DOI: 10.1007/978-981-15-3024-1_12] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
84 Canton C, Ceballos L, Domínguez MP, Fiel C, Lirón JP, Moreno L, Canton L, Bernat G, Lanusse C, Alvarez LI. Impact on beef cattle productivity of infection with anthelmintic-resistant nematodes. N Z Vet J 2020;68:187-92. [PMID: 31778612 DOI: 10.1080/00480169.2019.1698999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Jimenez Castro PD, Howell SB, Schaefer JJ, Avramenko RW, Gilleard JS, Kaplan RM. Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat? Parasit Vectors 2019;12:576. [PMID: 31818311 DOI: 10.1186/s13071-019-3828-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 12.3] [Reference Citation Analysis]
86 McTier TL, Six RH, Pullins A, Chapin S, Kryda K, Mahabir SP, Woods DJ, Maeder SJ. Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs. Parasit Vectors 2019;12:444. [PMID: 31506088 DOI: 10.1186/s13071-019-3685-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
87 Kryda K, Six RH, Walsh KF, Holzmer SJ, Chapin S, Mahabir SP, Myers M, Inskeep T, Rugg J, Cundiff B, Pullins A, Ulrich M, McCall JW, McTier TL, Maeder SJ. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors 2019;12:445. [PMID: 31506094 DOI: 10.1186/s13071-019-3702-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
88 Getachew B, Tizabi Y. Antidepressant effects of moxidectin, an antiparasitic drug, in a rat model of depression. Behav Brain Res 2019;376:112220. [PMID: 31513828 DOI: 10.1016/j.bbr.2019.112220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
89 Genchi M, Vismarra A, Lucchetti C, Viglietti A, Crosara S, Gnudi G, Quintavalla C, Schaper R, Kramer L. Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs. Vet Parasitol 2019;273:11-6. [PMID: 31442887 DOI: 10.1016/j.vetpar.2019.07.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
90 McTier TL, Kryda K, Wachowski M, Mahabir S, Ramsey D, Rugg D, Mazaleski M, Therrien C, Adams E, Wolff T, Bowman DD. ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months. Parasit Vectors 2019;12:369. [PMID: 31349867 DOI: 10.1186/s13071-019-3632-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
91 Njume FN, Ghogomu SM, Shey RA, Gainkam LOT, Poelvoorde P, Humblet P, Kamgno J, Robert A, Mutesa L, Lelubre C, Edelweiss E, Poterszman A, Anheuser S, Vanhamme L, Souopgui J. Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein. PLoS Negl Trop Dis 2019;13:e0007591. [PMID: 31329585 DOI: 10.1371/journal.pntd.0007591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
92 Prichard RK, Geary TG. Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance. Int J Parasitol Drugs Drug Resist 2019;10:69-83. [PMID: 31229910 DOI: 10.1016/j.ijpddr.2019.06.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
93 Preston S, Piedrafita D, Sandeman M, Cotton S. The current status of anthelmintic resistance in a temperate region of Australia; implications for small ruminant farm management. Vet Parasitol Reg Stud Reports 2019;17:100313. [PMID: 31303219 DOI: 10.1016/j.vprsr.2019.100313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Virkel G, Ballent M, Lanusse C, Lifschitz A. Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications. CMC 2019;26:1251-69. [DOI: 10.2174/0929867325666180201094730] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
95 Berrafato T, Coates R, Reaves BJ, Kulke D, Wolstenholme AJ. Macrocyclic lactone anthelmintic-induced leukocyte binding to Dirofilaria immitis microfilariae: Influence of the drug resistance status of the parasite. Int J Parasitol Drugs Drug Resist 2019;10:45-50. [PMID: 31054498 DOI: 10.1016/j.ijpddr.2019.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
96 Rodríguez-vivas RI, Basto-estrella GDS, Reyes-novelo E, Arcila-fuentes W, Ojeda-chi M, Trinidad-martínez I, Martínez-m I. Sub-lethal effects of moxidectin on the Neotropical dung beetle Onthophagus landolti Harold (Coleoptera: Scarabaeinae). Journal of Asia-Pacific Entomology 2019;22:239-242. [DOI: 10.1016/j.aspen.2019.01.005] [Reference Citation Analysis]
97 Fazzio L, Moreno L, Galvan W, Canton C, Alvarez L, Streitenberger N, Sánchez R, Lanusse C, Sanabria R. Pharmacokinetic profile and anthelmintic efficacy of moxidectin administered by different doses and routes to feedlot calves. Veterinary Parasitology 2019;266:73-9. [DOI: 10.1016/j.vetpar.2018.12.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
98 Rohdich N, Zschiesche E, Wolf O, Loehlein W, Kirkova Z, Iliev P, Rapti D, Postoli R, Capári B, Farkas R, Roepke RKA. A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus). Parasit Vectors 2018;11:589. [PMID: 30449275 DOI: 10.1186/s13071-018-3169-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, Roepke RKA. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Parasit Vectors 2018;11:598. [PMID: 30454052 DOI: 10.1186/s13071-018-3175-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
100 Gopinath H, Aishwarya M, Karthikeyan K. Tackling scabies: novel agents for a neglected disease. Int J Dermatol 2018;57:1293-8. [PMID: 29663338 DOI: 10.1111/ijd.13999] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
101 Smit MR, Ochomo EO, Waterhouse D, Kwambai TK, Abong'o BO, Bousema T, Bayoh NM, Gimnig JE, Samuels AM, Desai MR, Phillips-Howard PA, Kariuki SK, Wang D, Ter Kuile FO, Ward SA, Aljayyoussi G. Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL). Clin Pharmacol Ther 2019;105:388-401. [PMID: 30125353 DOI: 10.1002/cpt.1219] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
102 Opoku NO, Bakajika DK, Kanza EM, Howard H, Mambandu GL, Nyathirombo A, Nigo MM, Kasonia K, Masembe SL, Mumbere M, Kataliko K, Larbelee JP, Kpawor M, Bolay KM, Bolay F, Asare S, Attah SK, Olipoh G, Vaillant M, Halleux CM, Kuesel AC. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet 2018;392:1207-16. [PMID: 29361335 DOI: 10.1016/S0140-6736(17)32844-1] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 21.4] [Reference Citation Analysis]
103 Verdú JR, Cortez V, Martinez-Pinna J, Ortiz AJ, Lumaret JP, Lobo JM, Sánchez-Piñero F, Numa C. First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences. Sci Rep 2018;8:14885. [PMID: 30291291 DOI: 10.1038/s41598-018-33241-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
104 Gascoigne E, Morgan ER, Lovatt F, Vineer HR. Controlling nematode infections in sheep: application of HACCP. In pract 2018;40:334-47. [DOI: 10.1136/inp.k3858] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
105 Nashat MA, Ricart Arbona RJ, Lepherd ML, Santagostino SF, Livingston RS, Riedel ER, Lipman NS. Ivermectin-compounded Feed Compared with Topical Moxidectin-Imidacloprid for Eradication of Demodex musculi in Laboratory Mice. J Am Assoc Lab Anim Sci 2018;57:483-97. [PMID: 30185284 DOI: 10.30802/AALAS-JAALAS-18-000003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
106 Maheu-giroux M, Joseph SA. Moxidectin for deworming: from trials to implementation. The Lancet Infectious Diseases 2018;18:817-9. [DOI: 10.1016/s1473-3099(18)30270-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
107 Barda B, Ame SM, Ali SM, Albonico M, Puchkov M, Huwyler J, Hattendorf J, Keiser J. Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial. The Lancet Infectious Diseases 2018;18:864-73. [DOI: 10.1016/s1473-3099(18)30233-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
108 Song D, Liang H, Qu B, Li Y, Liu J, Chen C, Zhang D, Zhang X, Gao A. Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis. Oncol Rep 2018;40:1348-58. [PMID: 30015956 DOI: 10.3892/or.2018.6561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
109 Sangster NC, Cowling A, Woodgate RG. Ten Events That Defined Anthelmintic Resistance Research. Trends in Parasitology 2018;34:553-63. [DOI: 10.1016/j.pt.2018.05.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
110 Crisi PE, Di Cesare A, Boari A. Feline Troglostrongylosis: Current Epizootiology, Clinical Features, and Therapeutic Options. Front Vet Sci 2018;5:126. [PMID: 29974053 DOI: 10.3389/fvets.2018.00126] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
111 Cruz MDBA, Fernandes MÂM, Monteiro ALG, Teles JA, Anadón A, Reyes FGR. Tissue residue depletion of moxidectin in lambs ( Ovis aries ) following subcutaneous administration. Food Additives & Contaminants: Part A 2018;35:1278-85. [DOI: 10.1080/19440049.2018.1465207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
112 Cortés I, Kaufman TS, Bracca ABJ. A convenient and eco-friendly cerium(III) chloride-catalysed synthesis of methoxime derivatives of aromatic aldehydes and ketones. R Soc Open Sci 2018;5:180279. [PMID: 29892459 DOI: 10.1098/rsos.180279] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
113 Florez DHÂ, Teixeira RA, da Silva RCS, Pires BC, Dutra FVA, Borges KB. Pipette-tip solid-phase extraction using polypyrrole as efficient adsorbent for extraction of avermectins and milbemycins in milk. Anal Bioanal Chem 2018;410:3361-74. [DOI: 10.1007/s00216-018-1031-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
114 Casida JE. Radioligand Recognition of Insecticide Targets. J Agric Food Chem 2018;66:3277-90. [PMID: 29522334 DOI: 10.1021/acs.jafc.7b05984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
115 Spampanato J, Gibson A, Dudek FE. The antihelminthic moxidectin enhances tonic GABA currents in rodent hippocampal pyramidal neurons. J Neurophysiol 2018;119:1693-8. [PMID: 29364072 DOI: 10.1152/jn.00587.2017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
116 Misra-bhattacharya S, Shahab M. Progress in the Treatment and Control of Lymphatic Filariasis. Lymphatic Filariasis 2018. [DOI: 10.1007/978-981-13-1391-2_4] [Reference Citation Analysis]
117 Harras SF, Mona MH, Abdalla AG, Salim EI. Effect of bryostatin-1 as an anthelmintic drug on adult Syphacia muris infection in rats. JoBAZ 2017;78:8. [DOI: 10.1186/s41936-017-0013-3] [Reference Citation Analysis]
118 Fernandes MAM, Gilaverte S, Bianchi MD, da Silva CJA, Molento MB, Reyes FGR, Monteiro ALG. Moxidectin residues in tissues of lambs submitted to three endoparasite control programs. Research in Veterinary Science 2017;114:406-11. [DOI: 10.1016/j.rvsc.2017.07.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
119 Zha C, Wang C, Sheele JM. Effect of Moxidectin on Bed Bug Feeding, Development, Fecundity, and Survivorship. Insects 2017;8:E106. [PMID: 28973981 DOI: 10.3390/insects8040106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
120 Mermans C, Dermauw W, Geibel S, Van Leeuwen T. A G326E substitution in the glutamate-gated chloride channel 3 (GluCl3) of the two-spotted spider mite Tetranychus urticae abolishes the agonistic activity of macrocyclic lactones: Abolition of agonistic activity of macrocyclic lactones. Pest Manag Sci 2017;73:2413-8. [DOI: 10.1002/ps.4677] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
121 Song X, Zhang Y, Xue J, Li C, Wang Z, Wang Y. Enhancing nemadectin production by Streptomyces cyaneogriseus ssp. noncyanogenus through quantitative evaluation and optimization of dissolved oxygen and shear force. Bioresour Technol 2018;255:180-8. [PMID: 29414165 DOI: 10.1016/j.biortech.2017.09.033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
122 Mounsey KE, Walton SF, Innes A, Cash-Deans S, McCarthy JS. In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei. Antimicrob Agents Chemother 2017;61:e00381-17. [PMID: 28559258 DOI: 10.1128/AAC.00381-17] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
123 Peterson EM, Wooten KJ, Subbiah S, Anderson TA, Longing S, Smith PN. Agrochemical Mixtures Detected on Wildflowers near Cattle Feed Yards. Environ Sci Technol Lett 2017;4:216-20. [DOI: 10.1021/acs.estlett.7b00123] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
124 Mani T, Bourguinat C, Prichard RK. Polymorphism in ABC transporter genes of Dirofilaria immitis. Int J Parasitol Drugs Drug Resist 2017;7:227-35. [PMID: 28494332 DOI: 10.1016/j.ijpddr.2017.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
125 Laing R, Gillan V, Devaney E. Ivermectin - Old Drug, New Tricks? Trends Parasitol 2017;33:463-72. [PMID: 28285851 DOI: 10.1016/j.pt.2017.02.004] [Cited by in Crossref: 184] [Cited by in F6Publishing: 143] [Article Influence: 30.7] [Reference Citation Analysis]
126 Brownjohn PW, Smith J, Portelius E, Serneels L, Kvartsberg H, De Strooper B, Blennow K, Zetterberg H, Livesey FJ. Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease. Stem Cell Reports. 2017;8:870-882. [PMID: 28285880 DOI: 10.1016/j.stemcr.2017.02.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 7.7] [Reference Citation Analysis]
127 Keegan JD, Keane OM, Good B, De Waal T, Denny M, Hanrahan JP, Fitzgerald W, Sheehan M. A nationwide survey of anthelmintic treatment failure on sheep farms in Ireland. Ir Vet J 2017;70:7. [PMID: 28203368 DOI: 10.1186/s13620-017-0086-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
128 Prichard RK. Drug Resistance in Nematodes. Antimicrobial Drug Resistance 2017. [DOI: 10.1007/978-3-319-46718-4_46] [Reference Citation Analysis]
129 Eichberg C, Wohde M, Müller K, Rausch A, Scherrmann C, Scheuren T, Düring RA, Donath TW. The Anthelmintic Ingredient Moxidectin Negatively Affects Seed Germination of Three Temperate Grassland Species. PLoS One 2016;11:e0166366. [PMID: 27846249 DOI: 10.1371/journal.pone.0166366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
130 Bernigaud C, Fang F, Fischer K, Lespine A, Aho LS, Dreau D, Kelly A, Sutra JF, Moreau F, Lilin T, Botterel F, Guillot J, Chosidow O. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model. PLoS Negl Trop Dis 2016;10:e0005030. [PMID: 27732588 DOI: 10.1371/journal.pntd.0005030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
131 Huynh N, Arabian N, Naito A, Louie S, Jakowec MW, Asatryan L, Davies DL. Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder. Neuropharmacology 2017;113:60-70. [PMID: 27641072 DOI: 10.1016/j.neuropharm.2016.09.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
132 David MA, Orlowski S, Prichard RK, Hashem S, André F, Lespine A. In silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1. Int J Parasitol Drugs Drug Resist 2016;6:299-313. [PMID: 27746191 DOI: 10.1016/j.ijpddr.2016.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
133 Ferreira LE, Benincasa BI, Fachin AL, França SC, Contini SS, Chagas AC, Beleboni RO. Thymus vulgaris L. essential oil and its main component thymol: Anthelmintic effects against Haemonchus contortus from sheep. Veterinary Parasitology 2016;228:70-6. [DOI: 10.1016/j.vetpar.2016.08.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
134 Mani T, Bourguinat C, Keller K, Ashraf S, Blagburn B, Prichard RK. Interaction of macrocyclic lactones with a Dirofilaria immitis P-glycoprotein. International Journal for Parasitology 2016;46:631-40. [DOI: 10.1016/j.ijpara.2016.04.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
135 Ballesteros C, Tritten L, O'Neill M, Burkman E, Zaky WI, Xia J, Moorhead A, Williams SA, Geary TG. The Effects of Ivermectin on Brugia malayi Females In Vitro: A Transcriptomic Approach. PLoS Negl Trop Dis 2016;10:e0004929. [PMID: 27529747 DOI: 10.1371/journal.pntd.0004929] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
136 Traversa D, Di Cesare A. Diagnosis and management of lungworm infections in cats: Cornerstones, dilemmas and new avenues. J Feline Med Surg 2016;18:7-20. [PMID: 26733545 DOI: 10.1177/1098612X15623113] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 9.0] [Reference Citation Analysis]
137 Ménez C, Alberich M, Kansoh D, Blanchard A, Lespine A. Acquired Tolerance to Ivermectin and Moxidectin after Drug Selection Pressure in the Nematode Caenorhabditis elegans. Antimicrob Agents Chemother 2016;60:4809-19. [PMID: 27246778 DOI: 10.1128/AAC.00713-16] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
138 Elsheikha HM, Schnyder M, Traversa D, Di Cesare A, Wright I, Lacher DW. Updates on feline aelurostrongylosis and research priorities for the next decade. Parasit Vectors 2016;9:389. [PMID: 27387914 DOI: 10.1186/s13071-016-1671-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
139 Mani T, Bourguinat C, Keller K, Carreton E, Peregrine A, Prichard RK. Polymorphism in ion channel genes of Dirofilaria immitis: Relevant knowledge for future anthelmintic drug design. Int J Parasitol Drugs Drug Resist 2016;6:343-55. [PMID: 27682347 DOI: 10.1016/j.ijpddr.2016.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
140 Zhao R, Grunke SD, Keralapurath MM, Yetman MJ, Lam A, Lee TC, Sousounis K, Jiang Y, Swing DA, Tessarollo L, Ji D, Jankowsky JL. Impaired Recall of Positional Memory following Chemogenetic Disruption of Place Field Stability. Cell Rep 2016;16:793-804. [PMID: 27373150 DOI: 10.1016/j.celrep.2016.06.032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
141 Bernigaud C, Monsel G, Delaunay P, Do-Pham G, Foulet F, Botterel F, Chosidow O. [Main parasitic skin disorders]. Rev Med Interne 2017;38:17-27. [PMID: 27372516 DOI: 10.1016/j.revmed.2016.05.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
142 Whittaker JH, Carlson SA, Jones DE, Brewer MT. Molecular mechanisms for anthelmintic resistance in strongyle nematode parasites of veterinary importance. J Vet Pharmacol Ther 2017;40:105-15. [PMID: 27302747 DOI: 10.1111/jvp.12330] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
143 Kuesel AC. Research for new drugs for elimination of onchocerciasis in Africa. Int J Parasitol Drugs Drug Resist 2016;6:272-86. [PMID: 27693536 DOI: 10.1016/j.ijpddr.2016.04.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
144 Besier RB, Kahn LP, Sargison ND, Van Wyk JA. Diagnosis, Treatment and Management of Haemonchus contortus in Small Ruminants. Adv Parasitol 2016;93:181-238. [PMID: 27238006 DOI: 10.1016/bs.apar.2016.02.024] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
145 Sheele JM, Ridge GE. Toxicity and potential utility of ivermectin and moxidectin as xenointoxicants against the common bed bug, Cimex lectularius L. Parasitol Res 2016;115:3071-81. [DOI: 10.1007/s00436-016-5062-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
146 Fazzio LE, Streitenberger N, Galvan WR, Sánchez RO, Gimeno EJ, Sanabria RE. Efficacy and productive performance of moxidectin in feedlot calves infected with nematodes resistant to ivermectin. Vet Parasitol 2016;223:26-9. [PMID: 27198772 DOI: 10.1016/j.vetpar.2016.04.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
147 Lanusse CE, Alvarez LI, Lifschitz AL. Gaining Insights Into the Pharmacology of Anthelmintics Using Haemonchus contortus as a Model Nematode. Adv Parasitol 2016;93:465-518. [PMID: 27238011 DOI: 10.1016/bs.apar.2016.02.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
148 Mounsey KE, Bernigaud C, Chosidow O, McCarthy JS. Prospects for Moxidectin as a New Oral Treatment for Human Scabies. PLoS Negl Trop Dis 2016;10:e0004389. [PMID: 26985995 DOI: 10.1371/journal.pntd.0004389] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
149 Salgado JA, Santos CDP. Overview of anthelmintic resistance of gastrointestinal nematodes of small ruminants in Brazil. Rev Bras Parasitol Vet 2016;25:3-17. [DOI: 10.1590/s1984-29612016008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
150 Bowman DD, Charles SD, Arther RG, Settje T. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs. Parasitol Res 2015;114 Suppl 1:S165-74. [PMID: 26152417 DOI: 10.1007/s00436-015-4522-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
151 Godoy P, Che H, Beech RN, Prichard RK. Characterisation of P-glycoprotein-9.1 in Haemonchus contortus. Parasit Vectors 2016;9:52. [PMID: 26822677 DOI: 10.1186/s13071-016-1317-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
152 Godoy P, Che H, Beech RN, Prichard RK. Characterization of Haemonchus contortus P-glycoprotein-16 and its interaction with the macrocyclic lactone anthelmintics. Mol Biochem Parasitol 2015;204:11-5. [PMID: 26657092 DOI: 10.1016/j.molbiopara.2015.12.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
153 Jin L, Wang R, Zhu Y, Zheng W, Han Y, Guo F, Ye FB, Li Y. Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease. Sci Rep 2015;5:17288. [PMID: 26620317 DOI: 10.1038/srep17288] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
154 Geurden T, Chartier C, Fanke J, di Regalbono AF, Traversa D, von Samson-Himmelstjerna G, Demeler J, Vanimisetti HB, Bartram DJ, Denwood MJ. Anthelmintic resistance to ivermectin and moxidectin in gastrointestinal nematodes of cattle in Europe. Int J Parasitol Drugs Drug Resist 2015;5:163-71. [PMID: 26448902 DOI: 10.1016/j.ijpddr.2015.08.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 10.0] [Reference Citation Analysis]
155 Scherr N, Pluschke G, Thompson CJ, Ramón-García S. Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment. PLoS Negl Trop Dis 2015;9:e0003996. [PMID: 26270480 DOI: 10.1371/journal.pntd.0003996] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
156 Kose LP, Gülçin İ, Özdemir H, Atasever A, Alwasel SH, Supuran CT. The effects of some avermectins on bovine carbonic anhydrase enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry 2016;31:773-8. [DOI: 10.3109/14756366.2015.1064406] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
157 Tyagi R, Joachim A, Ruttkowski B, Rosa BA, Martin JC, Hallsworth-Pepin K, Zhang X, Ozersky P, Wilson RK, Ranganathan S, Sternberg PW, Gasser RB, Mitreva M. Cracking the nodule worm code advances knowledge of parasite biology and biotechnology to tackle major diseases of livestock. Biotechnol Adv 2015;33:980-91. [PMID: 26026709 DOI: 10.1016/j.biotechadv.2015.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
158 Lloberas M, Alvarez L, Entrocasso C, Ballent M, Virkel G, Luque S, Lanusse C, Lifschitz A. Comparative pharmacokinetic and pharmacodynamic response of single and double intraruminal doses of ivermectin and moxidectin in nematode-infected lambs. N Z Vet J 2015;63:227-34. [PMID: 25689407 DOI: 10.1080/00480169.2015.1015645] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
159 Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, Basáñez MG. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors 2015;8:167. [PMID: 25889256 DOI: 10.1186/s13071-015-0779-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 6.5] [Reference Citation Analysis]
160 Little SE, Hostetler JA, Thomas JE, Bailey KL, Barrett AW, Gruntmeir K, Gruntmeir J, Starkey LA, Basel C, Blagburn BL. Moxidectin steady state prior to inoculation protects cats from subsequent, repeated infection with Dirofilaria immitis. Parasit Vectors 2015;8:107. [PMID: 25880531 DOI: 10.1186/s13071-015-0710-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
161 Godoy P, Lian J, Beech RN, Prichard RK. Haemonchus contortus P-glycoprotein-2: in situ localisation and characterisation of macrocyclic lactone transport. International Journal for Parasitology 2015;45:85-93. [DOI: 10.1016/j.ijpara.2014.09.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
162 Verma M, Pathak M, Shahab M, Singh K, Mitra K, Misra-bhattacharya S. Moxidectin causes adult worm mortality of human lymphatic filarial parasite Brugia malayi in rodent models. FOLIA PARASIT 2014;61:561-70. [DOI: 10.14411/fp.2014.068] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
163 Neves JHD, Carvalho N, Rinaldi L, Cringoli G, Amarante AF. Diagnosis of anthelmintic resistance in cattle in Brazil: A comparison of different methodologies. Veterinary Parasitology 2014;206:216-26. [DOI: 10.1016/j.vetpar.2014.10.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
164 Urdaneta-Marquez L, Bae SH, Janukavicius P, Beech R, Dent J, Prichard R. A dyf-7 haplotype causes sensory neuron defects and is associated with macrocyclic lactone resistance worldwide in the nematode parasite Haemonchus contortus. Int J Parasitol 2014;44:1063-71. [PMID: 25224687 DOI: 10.1016/j.ijpara.2014.08.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
165 Bygarski EE, Prichard RK, Ardelli BF. Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes. Int J Parasitol Drugs Drug Resist 2014;4:143-51. [PMID: 25516824 DOI: 10.1016/j.ijpddr.2014.06.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
166 Kotze AC, Ruffell AP, Knox MR, Kelly GA. Relative potency of macrocyclic lactones in in vitro assays with larvae of susceptible and drug-resistant Australian isolates of Haemonchus contortus and H. placei. Veterinary Parasitology 2014;203:294-302. [DOI: 10.1016/j.vetpar.2014.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
167 Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis 2014;8:e2953. [PMID: 24968000 DOI: 10.1371/journal.pntd.0002953] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 7.9] [Reference Citation Analysis]
168 Zanzani SA, Gazzonis AL, Di Cerbo A, Varady M, Manfredi MT. Gastrointestinal nematodes of dairy goats, anthelmintic resistance and practices of parasite control in Northern Italy. BMC Vet Res 2014;10:114. [PMID: 24886141 DOI: 10.1186/1746-6148-10-114] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
169 Lanusse C, Alvarez L, Lifschitz A. Pharmacological knowledge and sustainable anthelmintic therapy in ruminants. Vet Parasitol 2014;204:18-33. [PMID: 24315694 DOI: 10.1016/j.vetpar.2013.11.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
170 Pérez-fernández R, Palma C, Díaz J, Salazar A. Verapamil modifies maternal pharmacokinetics and increases the transplacental exchange of moxidectin in pregnant sheep. Small Ruminant Research 2013;115:94-8. [DOI: 10.1016/j.smallrumres.2013.07.012] [Reference Citation Analysis]
171 Lespine A. Lipid-like properties and pharmacology of the anthelmintic macrocyclic lactones. Expert Opinion on Drug Metabolism & Toxicology 2013;9:1581-95. [DOI: 10.1517/17425255.2013.832200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
172 Khaldoun-oularbi H, Richeval C, Djenas N, Lhermitte M, Humbert L, Baz A. Effect of sub-acute exposure to abamectin “insecticide” on liver rats ( Rattus norvegicus ). Ann Toxicol Anal 2013;25:63-70. [DOI: 10.1051/ata/2013039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
173 Dolinská M, Königová A, Letková V, Molnár L, Várady M. Detection of ivermectin resistance by a larval development test--back to the past or a step forward? Vet Parasitol 2013;198:154-8. [PMID: 23993637 DOI: 10.1016/j.vetpar.2013.07.043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
174 Demeler J, Gill JH, von Samson-Himmelstjerna G, Sangster NC. The in vitro assay profile of macrocyclic lactone resistance in three species of sheep trichostrongyloids. Int J Parasitol Drugs Drug Resist 2013;3:109-18. [PMID: 24533300 DOI: 10.1016/j.ijpddr.2013.04.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
175 Lloberas M, Alvarez L, Entrocasso C, Virkel G, Ballent M, Mate L, Lanusse C, Lifschitz A. Comparative tissue pharmacokinetics and efficacy of moxidectin, abamectin and ivermectin in lambs infected with resistant nematodes: Impact of drug treatments on parasite P-glycoprotein expression. Int J Parasitol Drugs Drug Resist 2013;3:20-7. [PMID: 24533290 DOI: 10.1016/j.ijpddr.2012.11.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
176 Ménez C, Sutra JF, Prichard R, Lespine A. Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis 2012;6:e1883. [PMID: 23133688 DOI: 10.1371/journal.pntd.0001883] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]